Company: ARMP
Filing Date: 2025-12-01
Form Type: 424B5
Source: 0001104659-25-117382
Chunk: 45

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-12-01
Form: 424B5
Chunk 45
---
additional risks and uncertainties actually occur, our business, financial condition and results of operations could be materially and
adversely affected.

In that case, the trading
price of our securities could decline and you might lose all or part of the value of your investment.

<div align='center'>8

THE SECURITIES WE MAY OFFER</div>

We may offer up to $100,000,000
of shares of our common stock, preferred stock, debt securities, warrants or units in any combination of the foregoing, under this prospectus
at prices and on terms to be determined by market conditions at the time of offering. This prospectus provides you with a general description
of the securities we may offer. Each time we offer a type or series of securities, we will provide a prospectus supplement that will describe
the specific amounts, prices and other important terms of the securities.

A prospectus supplement and
any related free writing prospectus that we may authorize to be provided to you also may add, update or change information contained in
this prospectus or in documents we have incorporated by reference.

This prospectus may not be used to offer or sell securities unless it is accompanied by a prospectus supplement.

We may sell the securities
directly to or through agents, underwriters or dealers. We, and our agents, dealers or underwriters, reserve the right to accept or reject
all or part of any proposed purchase of securities. If we do offer securities through agents or underwriters, we will include in the applicable
prospectus supplement:

| · | the name of those agents or underwriters; |

| · | applicable fees, discounts and commissions to 
 be paid to them;                              |

| · | details regarding options to purchase additional 
 securities, if any; and                          |

| · | the net proceeds to us. |

Common Stock.

We may issue shares of our
common stock from time to time. Holders of our common stock are entitled to one vote per share on all matters submitted to a vote of shareholders.
Subject to any preferences of any of our preferred stock that may be outstanding, holders of our common stock are entitled to dividends
when and if declared by our board of directors.

Preferred Stock.

Our board of directors has
the authority, subject to limitations prescribed by Washington law, to issue preferred stock in one or more series, to establish from
time to time the number of shares to be included in each series, and to fix or alter the rights, preferences and privileges of the preferred